Announcement on Approval of Marketing Authorization for Qianlie Shutong Capsules in Indonesia
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Approval of Marketing Authorization for Qianlie Shutong Capsules in Indonesia
Filed with SSE · Stock code 603858 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix
Earlier from Shandong Buchang Pharmaceuticals
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on the Profit Distribution Plan for the First Half of 2026
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Obtaining Drug Registration Certificate
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Signing of Technology Transfer Contract by Wholly-owned Subsidiary
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Resolutions of the 57th Meeting of the 5th Board of Directors
- (603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Proposed External Investment by Controlled Subsidiary for Establishment of Wholly-owned Subsidiary
Follow Shandong Buchang Pharmaceuticals into a list and get an email when it puts out news.
Follow Shandong Buchang Pharmaceuticals